Health Sciences Research
Baricitinib speeds COVID-19 recovery in NIAID trial
In a randomized, controlled trial of more than 1,000 adults hospitalized with COVID-19 pneumonia, treatment with the anti-inflammatory drug baricitinib resulted in faster recovery and a greater likelihood of clinical improvement, when combined with the antiviral drug remdesivir. Read More >>
Some postmenopausal women with breast cancer may forgo chemotherapy, Emory researcher says
Postmenopausal women with HR-positive, HER2-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is relatively low, do not benefit from chemotherapy when it is added to hormone therapy. News Story >>
Emory begins Phase 3 study of Novavax COVID-19 vaccine
Emory is participating in a new Phase 3 vaccine clinical trial for COVID-19. The clinical trial will test the safety and effectiveness of an investigational protein-based vaccine developed by U.S. Novavax, Inc. News Story >>
